摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-(Pyridin-2-YL)hexanoic acid

中文名称
——
中文别名
——
英文名称
6-(Pyridin-2-YL)hexanoic acid
英文别名
6-pyridin-2-ylhexanoic acid
6-(Pyridin-2-YL)hexanoic acid化学式
CAS
——
化学式
C11H15NO2
mdl
MFCD06496347
分子量
193.24
InChiKey
WSMRJBYOIBBOQN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    14
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.454
  • 拓扑面积:
    50.2
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • Mitofusin activators and methods of use thereof
    申请人:MITOCHONDRIA EMOTION, INC.
    公开号:US11026904B2
    公开(公告)日:2021-06-08
    Compositions including small molecule mitofusin activators are described. The mitofusin activators are useful for treating diseases or disorders associated with a mitochondria-associated disease, disorder, or condition such as diseases or disorders associated with mitofusin 1 (MFN1) and/or mitofusin 2 (MFN2), or mitochondrial dysfunction. Methods of treatment, pharmaceutical formulations, and screening methods for identifying compounds that activate mitochondrial fusion are also described.
    本文描述了包括小分子丝裂霉素激活剂的组合物。丝裂蛋白激活剂可用于治疗与线粒体相关的疾病或失调,如与丝裂蛋白1(MFN1)和/或丝裂蛋白2(MFN2)或线粒体功能障碍相关的疾病或失调。此外,还介绍了治疗方法、药物制剂以及用于鉴定激活线粒体融合的化合物的筛选方法。
  • LEUKOTRIENE B 4? ANALOGS
    申请人:THE UPJOHN COMPANY
    公开号:EP0339046A1
    公开(公告)日:1989-11-02
  • LEUKOTRIENE B 4 ANALOGS
    申请人:THE UPJOHN COMPANY
    公开号:EP0339046B1
    公开(公告)日:1995-02-15
  • MITOFUSIN ACTIVATORS AND METHODS OF USE THEREOF
    申请人:MITOCHONDRIA EMOTION, INC.
    公开号:US20200345669A1
    公开(公告)日:2020-11-05
    Compositions including small molecule mitofusin activators are described. The mitofusin activators are useful for treating diseases or disorders associated with a mitochondria-associated disease, disorder, or condition such as diseases or disorders associated with mitofusin 1 (MFN1) and/or mitofusin 2 (MFN2), or mitochondrial dysfunction. Methods of treatment, pharmaceutical formulations, and screening methods for identifying compounds that activate mitochondrial fusion are also described.
  • US5116981A
    申请人:——
    公开号:US5116981A
    公开(公告)日:1992-05-26
查看更多